» Articles » PMID: 32802574

Stereotactic Radiotherapy for Large Vestibular Schwannomas: Volume Change Following Single Fraction Versus Hypofractionated Approaches

Overview
Date 2020 Aug 18
PMID 32802574
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Hypofractionated stereotactic radiotherapy is a treatment option for large vestibular schwannomas supported by an increasing evidence. A single institution retrospective review of large (>3.5cc) vestibular schwannomas treated with hypofractionated stereotactic radiotherapy and single-session radiosurgery was conducted. Using serial follow up scans, a volumetric analysis of tumor volume change over time was performed. Vestibular schwannomas treated with hypofractionated stereotactic radiotherapy appeared to reduce in volume significantly faster than those treated with single-session radiosurgery. Cystic lesions reduced in volume faster than solid lesions. There was no significant difference in the rates of radiological and symptomatic oedema, nor subsequent dexamethasone requirement between the two treatment modalities.

Citing Articles

Treatment options for unilateral vestibular schwannoma: a network meta-analysis.

Huo X, Zhao X, Liu X, Zhang Y, Tian J, Li M BMC Cancer. 2024; 24(1):1490.

PMID: 39627752 PMC: 11613487. DOI: 10.1186/s12885-024-13242-1.


Management of treatment-naïve Koos grade IV vestibular schwannomas using hypofractionated Gamma Knife radiosurgery: a retrospective single-institution study.

Samanci Y, Tepebasili M, Duzkalir A, Askeroglu M, Peker S Neurosurg Rev. 2024; 47(1):874.

PMID: 39589528 DOI: 10.1007/s10143-024-03125-1.


The Recent Management of Vestibular Schwannoma Radiotherapy: A Narrative Review of the Literature.

Brun L, Mom T, Guillemin F, Puechmaille M, Khalil T, Biau J J Clin Med. 2024; 13(6).

PMID: 38541837 PMC: 10971037. DOI: 10.3390/jcm13061611.


Single-fraction radiosurgery outcomes for large vestibular schwannomas in the upfront or post-surgical setting: a systematic review and International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines.

Tuleasca C, Kotecha R, Sahgal A, de Salles A, Fariselli L, Paddick I J Neurooncol. 2023; 165(1):1-20.

PMID: 37843727 PMC: 10638172. DOI: 10.1007/s11060-023-04455-8.

References
1.
Anderson B, Khuntia D, Bentzen S, Geye H, Hayes L, Kuo J . Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery. J Neurooncol. 2013; 116(1):187-93. DOI: 10.1007/s11060-013-1282-4. View

2.
Slane B, Goyal U, Grow J, Morrison C, Hullett C, Gordon J . Radiotherapeutic management of vestibular schwannomas using size- and location-adapted fractionation regimens to maximize the therapeutic ratio. Pract Radiat Oncol. 2017; 7(3):e233-e241. DOI: 10.1016/j.prro.2016.10.016. View

3.
Patel M, Marciscano A, Hu C, Jusue-Torres I, Garg R, Rashid A . Long-term Treatment Response and Patient Outcomes for Vestibular Schwannoma Patients Treated with Hypofractionated Stereotactic Radiotherapy. Front Oncol. 2017; 7:200. PMC: 5591320. DOI: 10.3389/fonc.2017.00200. View

4.
Wong R, Low H, Tan D . Local experience with radiosurgery for vestibular schwannomas and recommendations for management. Singapore Med J. 2018; 59(11):590-596. PMC: 6250757. DOI: 10.11622/smedj.2018107. View

5.
Shirato H, Sakamoto T, Takeichi N, Aoyama H, Suzuki K, Kagei K . Fractionated stereotactic radiotherapy for vestibular schwannoma (VS): comparison between cystic-type and solid-type VS. Int J Radiat Oncol Biol Phys. 2000; 48(5):1395-401. DOI: 10.1016/s0360-3016(00)00731-8. View